- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2020
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/12252
Title: | Severe community-acquired pneumonia: clinical manifestations in obese patients |
Authors: | Fetco-Mereuță, Diana Cașcaval, Virginia |
Keywords: | community-acquired pneumonia;obesity;complications |
Issue Date: | 2020 |
Publisher: | MedEspera |
Citation: | FETCO-MEREUȚĂ, Diana, CAȘCAVAL, Virginia. Severe community-acquired pneumonia: clinical manifestations in obese patients. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 166-167. |
Abstract: | Introduction. Community-acquired pneumonia is a leading cause of morbidity and mortality
worldwide, and is strongly influenced by comorbid conditions. Obesity is associated with
higher mortality rate directly proportional to higher body mass index. Obesity is also associated
with an increased risk of acquiring infections such as community-acquired pneumonia.
Aim of the study. To evaluate the obesity influence on clinical manifestations in patients with
severe community-acquired pneumonia.
Materials and methods. The retrospective case-control study was based on case histories
analysis of patients hospitalized with severe community-acquired pneumonia in the
Department of Internal Medicine, Sfânta Treime Municipal Hospital between years 2018 and
2019. The study were included 82 patients aged between 34 and 83 years, divided in two
groups: group 1 (41 patients with obesity) and group 2 (41 normal weight patients).
Results. Inavasive ventilation was necessary in 34% (28/82 patients), 16 patients with obesity
and 12 normal weight patients (19% vs 15%) (p>0.05). The mean duration of inavasive ventilation was 5.7±2.5 days in obese vs 5.5±3.7 days in normal weight patients. Among 82
patients, the main duration of hospitalization was 14.5±5.2 days. The obese patients lengths of
hospital stay was 15±3.2 days vs 13±2.4 days in normal weight patients (p<0.05). Duration of
antibacterial therapy was 19.3±7.3 days in obese and 18.2±5.8 days in normal weight patients
(p<0.05). The group of obese patients consisted of obesity class 1- 24.4% (10/41 patients),
class 2 - 26.8% (11/41 patients) and class 3 - 48.7% (20/41 patients). The presence of
complications in obese was reported in all the cases, of them - 100% of acute respiratory failure,
14.6% of ARDS, 39% of pleural effusion, 22% of cardiogenic pulmonary edema, 7% of sepsis
and 12% of multiple organ dysfunction syndrome.
Conclusions. The study revealed that obesity was positively associated with a longer
hospitalization stay and longer duration of antibacterial therapy. No association was found
between obesity and more frequent need for mechanical ventilation. The most severe
complications were registered in patients with class 3 obesity. |
URI: | https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf http://repository.usmf.md/handle/20.500.12710/12252 |
Appears in Collections: | MedEspera 2020
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|